tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Presentations

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

Fossil Group (FOSL) Q2 2026 Earnings Call: Margin Expansion Drives Raised Outlook

Fossil Group’s Q2 2026 earnings call covered a 62.4% gross margin, stronger watch sales, raised guidance and expected Q4 revenue growth.
iconFossil Group Inc
TradingKey
Fri, Aug 14

FGI Industries (FGI) Q2 2026 Earnings Call: Margin Expands, Guidance Reaffirmed

FGI Industries Q2 2026 earnings call: revenue rose 2.9%, gross margin reached 33.4%, profitability improved and full-year guidance was reaffirmed.
iconFGI Industries Ltd
TradingKey
Fri, Aug 14

Figure Technology Solutions (FIGR) Q2 2026 Earnings Call: Volume Jumps 132%

Figure Technology Solutions Q2 2026 earnings call: volume rose 132% to $4.3 billion, EBITDA margin reached 55%, and Q3 volume guidance was $4.8-$5.2 billion.
iconFigure Technology Solutions Inc
TradingKey
Fri, Aug 14

Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates

Journey Medical's Q2 2026 earnings call highlighted 23% revenue growth to $18.5 million, positive adjusted EBITDA and accelerating Emrosi prescriptions.
iconFortress Biotech Inc
TradingKey
Fri, Aug 14

EnerSys (ENS) Q1 Fiscal 2027 Earnings Call: Cash Flow, Data Center and Defense Growth

EnerSys fiscal Q1 2027 sales rose 5% to $936 million, free cash flow reached $218 million, and management issued Q2 EPS guidance of $3.15-$3.25.
iconEnerSys
TradingKey
Fri, Aug 14

Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call: Revenue Up 99%, Guidance Raised

Eton Pharmaceuticals Q2 2026 revenue rose 99% to $37.6 million as Hemangiol led growth, while management raised 2026 revenue guidance above $145 million.
iconEton Pharmaceuticals Inc
TradingKey
Fri, Aug 14

Vertical Aerospace (EVTL) Q2 2026 Earnings Call: $148M Cash and 2029 Valo Certification

Vertical Aerospace’s Q2 2026 earnings call covered $148 million of expected cash, a runway toward Q3 2027, Valo certification in 2029 and hybrid flight tests planned for 2027.
iconVertical Aerospace Ltd
TradingKey
Fri, Aug 14

Epsilon Energy (EPSN) Q2 2026 Earnings Call: Oil Growth and Parkman Ramp

Epsilon Energy’s Q2 2026 earnings call highlighted rising oil output, accelerated Parkman development, high-teens production growth guidance and debt reduction.
iconEpsilon Energy Ltd
TradingKey
Fri, Aug 14

Enovix (ENVX) Q2 2026 Earnings Call: Smart Eyewear Revenue Begins, Pipeline Reaches $183M

Enovix Q2 2026 revenue rose 21% to $9 million as smart eyewear sales began, smartphone testing advanced and its Korea pipeline reached $183 million.
iconEnovix Corp
TradingKey
Fri, Aug 14

Elmet Group (ELMT) Q2 2026 Earnings Call: Revenue Up 35%, Backlog Hits Record

Elmet Group Q2 2026 earnings call: revenue rose 35.2% to $66.4 million, gross margin reached 25%, and backlog increased 55% to $131.5 million.
iconElmet Group Ord Shs (Proposed)
TradingKey
Fri, Aug 14

ELUT Q2 2026 Earnings Call: NXT 41X Timeline, Funding and Margin Expansion

ELUT Q2 2026 sales fell to $2.4 million as margins improved. Management outlined NXT 41X FDA timelines, launch plans and funding through at least 2028.
iconElutia Inc
TradingKey
Fri, Aug 14

Dyadic International (DYAI) Q2 2026 Earnings Call: Commercial Progress and Liquidity Risk

Dyadic International Q2 2026 revenue held at $961,000 as commercialization advanced, while a $4.8 million liquidity position triggered going-concern risk.
iconDyadic International Inc
TradingKey
Fri, Aug 14

Brinker International (EAT) Q4 Fiscal 2026 Earnings Call: Chili’s Growth and FY2027 Guidance

Brinker International’s Q4 fiscal 2026 call covered 23% adjusted EPS growth, Chili’s traffic gains, Big Crispy momentum, and fiscal 2027 guidance.
iconBrinker International Inc
TradingKey
Fri, Aug 14

Journey Medical (DERM) Q2 2026 Earnings Call: Emrosi Drives 23% Revenue Growth

Journey Medical’s Q2 2026 earnings call covered 23% revenue growth, accelerating Emrosi prescriptions, positive adjusted EBITDA and improving payer coverage.
iconJourney Medical Corp
TradingKey
Fri, Aug 14

Dolphin Entertainment (DLPN) Q2 2026 Earnings Call: Revenue Rises 2.5%

Dolphin Entertainment (DLPN) Q2 2026 earnings call: revenue rose 2.5% to $14.4 million as bonuses and litigation costs weighed on EBITDA.
iconDolphin Entertainment Inc
TradingKey
Fri, Aug 14

Direct Digital Holdings (DRCT) Q2 2026 Earnings Call: Revenue Falls, AI Strategy Advances

Direct Digital Holdings Q2 2026 revenue fell to $7.8 million as DSP spending declined, while the company advanced its AI strategy and sought a covenant waiver.
iconDirect Digital Holdings Inc
TradingKey
Fri, Aug 14

Data I/O (DAIO) Q2 2026 Earnings Call: Gross Margin Reaches 57%

Data I/O Q2 2026 earnings call: sales rose 59% sequentially to $5.2 million, gross margin reached 57%, and adjusted EBITDA was near breakeven.
iconData I/O Corp
TradingKey
Fri, Aug 14

CVD Equipment (CVV) Q2 2026 Earnings Call: SDC Sale Strengthens Cash Position

CVD Equipment’s Q2 2026 earnings call covered a 43% revenue decline, the SDC divestiture, $23.5 million in cash, aerospace demand and backlog risks.
iconCVD Equipment Corp
TradingKey
Fri, Aug 14

CapsoVision (CV) Q2 2026 Earnings Call: Revenue Up 10%, AI Launch Advances

CapsoVision (CV) Q2 2026 revenue rose 10% to $3.6 million as capsule shipments grew 13%. Management targets U.S. AI Highlights clearance by Q3-end.
iconCapsoVision Inc
TradingKey
Fri, Aug 14

CuriosityStream (CURI) Q2 2026 Earnings Call: Licensing Drives Record EBITDA

CuriosityStream Q2 2026 earnings call: revenue rose 22% to $23.2 million, adjusted EBITDA hit $11.4 million, and full-year guidance was maintained.
iconCuriosityStream Inc
TradingKey
Fri, Aug 14
Featured Tools
marketing_marketsTitleMarketscalendar_economicCalendarEconomic Calendarsearch.intelligent.strategySmartPicksarticle_asider_weekly_reportWeekly Report
Popular Instruments
link
Name
Price
Chg%
US30
US30
US30
--
--
NAS100
NAS100
NAS100
--
--
SPX500
SPX500
US500
--
--
Top News
link
【US Pre-Market】US Stock Futures Rise Across the Board, Celestica Surges Over 15%, Gold Fluctuates Around $4,000, Bitcoin Drops Below $80,000 Level
Anthropic Publicly Files for Nasdaq IPO: Half-Year Revenue of $16.3 Billion, Net Loss of $80.7 Billion
Gold Rebounds Above $4,000 Ahead of Fed Decision as Oil Pullback Eases Inflation Fears
Meta Gains 0.12% Pre-Market as Nvidia Plans to Buy $3 Billion of Its Stock and Deepen Muse AI Collaboration
The Week Ahead: Fed Rate Decision Looming as Microsoft, Alphabet, and Amazon Report Earnings
Market Movers
link
Eaton Corporation PLC Stock (ETN) Moved Up by 3.33% on Oct 27: Facts Behind the Movement
23 minutes ago
ETN
--
Boeing Co Stock (BA) Moved Down by 9.88% on Oct 27: Drivers Behind the Movement
23 minutes ago
BA
--
Palo Alto Networks Inc Stock (PANW) Moved Up by 3.06% on Oct 27: Drivers Behind the Movement
23 minutes ago
PANW
--
Micron Technology Inc Stock (MU) Moved Up by 3.04% on Oct 27: A Full Analysis
23 minutes ago
MU
--
Accenture PLC Stock (ACN) Moved Down by 4.41% on Oct 27: Key Drivers Unveiled
23 minutes ago
ACN
--
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy